Molecule Details
InChIKeyHVXKQKFEHMGHSL-QKDCVEJESA-N
Canonical SMILESCOc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)21
Pfam Stratification Cross-Family
Avg pChEMBL7.02
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11973
Drug NameTesevatinib
CAS Number781613-23-8
Groups investigational
ATC Codes nan
DescriptionTesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs implicated in driving tumor cell proliferation and tumor vascularization (blood v...

Categories: Antineoplastic Agents Aza Compounds Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Protein Kinase Inhibitors Receptor, EphB4, antagonists & inhibitors Receptor, ErbB-2, antagonists & inhibitors Tyrosine Kinase Inhibitors Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
Cross-references: CHEMBL3544983 ChemSpider: 32699556 PubChem:10458325 PubChem:347828296 Wikipedia: Tesevatinib ZINC: ZINC000114456300
Target Activities (21)
Target Gene Organism Category Pfam pChEMBL Type Source
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 9.5 IC50 ChEMBL;BindingDB
Q16644 MAPKAPK3 Homo sapiens Human PF00069 8.7 Kd ChEMBL
P21709 EPHA1 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 8.1 Kd ChEMBL
Q15375 EPHA7 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 7.7 Kd ChEMBL
O43353 RIPK2 Homo sapiens Human PF00619 PF07714 7.5 Kd ChEMBL
P54760 EPHB4 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 7.4 Kd ChEMBL
P17948 FLT1 Homo sapiens Human PF07679 PF00047 PF13927 PF22971 PF07714 PF21339 PF17988 PF22854 7.3 IC50 ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 7.2 Kd ChEMBL
Q08345 DDR1 Homo sapiens Human PF21114 PF00754 PF07714 7.1 Kd ChEMBL
P11274 BCR Homo sapiens Human PF09036 PF00168 PF19057 PF00620 PF00621 7.0 Kd ChEMBL
Q13882 PTK6 Homo sapiens Human PF07714 PF00017 PF00018 6.8 Kd ChEMBL
P06239 LCK Homo sapiens Human PF07714 PF00017 PF00018 6.7 Kd ChEMBL
O15197 EPHB6 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF07647 6.6 Kd ChEMBL
Q9Y572 RIPK3 Homo sapiens Human PF00069 PF12721 6.4 Kd ChEMBL
P54764 EPHA4 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF07647 6.4 Kd ChEMBL
P29323 EPHB2 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 6.3 Kd ChEMBL
P29317 EPHA2 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 6.3 Kd ChEMBL
O14976 GAK Homo sapiens Human PF00069 PF10409 6.2 Kd ChEMBL
P42684 ABL2 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 6.2 Kd ChEMBL
P00519 ABL1 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 6.0 Kd ChEMBL
Q9Y4K4 MAP4K5 Homo sapiens Human PF00780 PF00069 6.0 Kd ChEMBL
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P01133 P01133 Pro-epidermal growth factor binder targets
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 binder targets
P54760 EPHB4 Ephrin type-B receptor 4 modulator targets